title: Reply to "Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit".
authors.affiliation: Department of Surgery, Erasmus-MC Medical Center, Rotterdam, The Netherlands Department of Surgery, Erasmus-MC Medical Center, Rotterdam, The Netherlands Department of Public Health, Erasmus-MC Medical Center, Rotterdam, The Netherlands Department of Surgery, Erasmus-MC Medical Center, Rotterdam, The Netherlands.
authors.forename: A Koen
authors.initials: AK
authors.lastname: Talsma
authors.forename: Bas P L
authors.initials: BP
authors.lastname: Wijnhoven
authors.forename: Ewout W
authors.initials: EW
authors.lastname: Steyerberg
authors.forename: J Jan B
authors.initials: JJ
authors.lastname: van Lanschot
mesh_terms: D004938:Esophageal Neoplasms; D016629:Esophagectomy; D006801:Humans; D008197:Lymph Node Excision; D020360:Neoadjuvant Therapy